Business Standard

Gufic Biosciences soars 14%, hits 52-week high on improved business outlook

Rating agency CRISIL Ratings has revised the company's outlook on the long-term bank facilities

Gufic Biosciences soars 14%; hits 52-week high on improved business outlook
Premium

SI Reporter Mumbai
Shares of Gufic Biosciences (Gufic) hit a 52-week high of Rs 283.50 after they rallied 14 per cent on the BSE in Tuesday's intra-day trade on the back of heavy volumes on improved business outlook.

At 09:51 AM, the stock was trading 11 per cent higher at Rs 274.75, as compared to 0.70 per cent decline in the S&P BSE Sensex. Trading volumes on the counter jumped over five-fold with a combined 2.01 million equity shares having changed hands on the NSE and BSE till the time of writing of this report.

Gufic, on Monday, announced that it

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in